Relationship between the Distance Traveled in the Test of 6- Minute Walk and Sex, Age, Comorbidities and Dyspnea in Patients with CORP
Article Sidebar
Main Article Content
Abstract
Introduction: chronic obstructive pulmonary disease (COPD) is a respiratory disorder characterized by clinical symptoms and functional impairment that affects aerobic capacity, limiting daily activities and quality of life. The 6-minute walk test (C6M) is a simple, low-cost test that assesses a patient's ability to perform their daily activities. Objective: to evaluate the relationship between aerobic capacity measured by the distance covered in the C6M and gender, age, dyspnea and cardiometabolic comorbidities in patients with COPD. Materials and methods: cross-sectional, descriptive study, based on 6-minute walk tests (C6M) performed in patients with COPD. Results: 101 male patients (63.4%), with a mean age of 74.1 ± 8.7 years, were evaluated. When correlating C6M with other variables, statistically significant differences were found. The mean distance traveled was greater in men than in women (MD: 58.3 meters, 95% CI: 16 - 100.6, p=0.007). Patients <75 years old, without comorbidities and dyspnea <2 had better performance in the C6M than those >75 years old (MD; 62 meters CI 95% 21.5 - 102.4, p=0.003), with comorbidities (MD: 42.2 meters, 95% CI, 0.003 - 84.4; p=0.050) and dyspnea ≥ 2 (MD: 65.8, 95% CI 23.9 - 107.6, p=0.002). Conclusions: female sex, the presence of cardiovascular and metabolic comorbidity, and age are associated with decreased aerobic and functional physical capacity in patients with COPD.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Global Initiative for Chronic Obstructive Lung Disease. 2022 Report [Internet]. [Consultado 11 abr 2023] Disponible en: https://goldcopd.org/2022-gold-reports/
Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10): 1005-12. Doi: 10.1056/NEJMoa021322
Waschki B, Spruit MA, Watz H et al. Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respiratory medicine 2012;106(4):522-30. Doi: 10.1016/j.rmed.2011.10.022
American Thoracic Society. AST Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002; 166: 111-117. Doi: 10.1164/ajrccm.166.1.at1102
Rasekaba T, Lee AL, Naughton MT et al. The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J 2009; 39 (8): 495-501. Doi: 10.1111/j.1445-5994.2008.01880.x
Singh SJ, Puhan MA, Andrianopoulos V et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014; 44:1447-78. Doi: 10.1183/09031936.00150414
Polkey MI, Spruit MA, Edwards LD et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013; 187:382-6. Doi: 10.1164/rccm.201209-1596OC
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581–586. Doi: 10.1136/thx.54.7.581
Mahler DA, Weinberg DH, Wells CK et al. The Measurement of Dyspnea. Contents, Interobserver Agreement, and Physiologic Correlates of Two New Clinical Indexes. Chest 1984; 85 (6): 751-758. Doi: 10.1378/chest.85.6.751
Cameron-Tucker HL, Wood-Baker R, Owen C, Joseph L, Walters EH. Chronic disease self-management and exercise in COPD as pulmonary rehabilitation: A randomized controlled trial. Int J Chron Obstruct Pulmon Dis 2014; 9: 513-23. Doi: 10.2147/COPD.S58478
Benavides V, Wilches-Luna E. Cambios en la puntuación del índice bode en pacientes con enfermedad pulmonar obstructiva crónica antes y después de rehabilitación pulmonar. Revista Ciencias de la Salud 2018; 16(1): 101-13. Doi: 10.12804/revistas.urosario.edu.co/revsalud/a.6493
Caballero A, Torres Duque C, Jaramillo C et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest 2008;133(2):343-9. DOI: 10.1378/chest.07-1361
Kinney GL, Black-Shinn JL, Wan ES et al. COPDGene Investigators. Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. Diabetes Care 2014;37(2):389–395. Doi: 10.2337/dc13-1435
Betancourt-Peña J, Benavides-Córdoba V, Avila-Valencia, Rosero-Carvajal H. Differences between COPD Patients of a Pulmonary Rehabilitation Program According to the mMRC Dyspnea Scale. Current Respiratory Medicine Reviews 2019; 15: 32-38. Doi: 10.2174/1573398X15666190404150703
Steffen TM, Hacker TA, Mollinguer L. Age- and Gender-Related Test Performance in Community-Dwelling Elderly People: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and Gait Speeds. Physical Therapy 2002; 82(2): 128-137. Doi: 10.1093/ptj/82.2.128
Spruit MA, Watkins WL, Edwards LD et al. Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort. Respiratory Medicine 2010; 104: 849-857. Doi: 10.1016/j.rmed.2009.12.007
Black-Shinn JL, Kinney GL, Wise AL et al. COPDGene Investigators. Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD 2014;11(5):546–551. Doi: 10.3109/15412555.2014.898029
Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management Semin Respir Crit Care Med 2015; 36(4): 575–591. Doi: 10.1055/s-0035-1556063
Patel A. Correlation of spirometry with six-minute walk test and grading of dyspnea. Eur Respir J 2015; 46. Doi: 10.1183/13993003.congress-2015.PA604